Larimar Therapeutics Stock Price History

Below is the normalized historical share price chart for Larimar Therapeutics extending back to June 19, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Larimar Therapeutics stands at 3.76, as last reported on the 24th of July, with the highest price reaching 3.83 and the lowest price hitting 3.37 during the day. If you're considering investing in Larimar Stock, it is important to understand the factors that can impact its price. Larimar Therapeutics is dangerous given 3 months investment horizon. Larimar Therapeutics has Sharpe Ratio of 0.15, which conveys that the firm had a 0.15 % return per unit of risk over the last 3 months. We have collected data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.02% are justified by taking the suggested risk. Use Larimar Therapeutics Mean Deviation of 5.19, downside deviation of 6.54, and Risk Adjusted Performance of 0.1697 to evaluate company specific risk that cannot be diversified away. At this time, Larimar Therapeutics' Common Stock Shares Outstanding is relatively stable compared to the past year. As of 07/24/2025, Common Stock is likely to grow to about 67.2 K, while Liabilities And Stockholders Equity is likely to drop slightly above 112.2 M. . At this time, Larimar Therapeutics' Price Book Value Ratio is relatively stable compared to the past year. As of 07/24/2025, Price To Book Ratio is likely to grow to 1.45, while Price Earnings To Growth Ratio is likely to drop (0.05). Larimar Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1482

Best Portfolio	Best Equity
Good Returns
Average Returns
Small Returns				LRMR
Cash	Small Risk	Average Risk	High Risk	Huge Risk
Negative Returns

Estimated Market Risk

Expected Return

Risk-Adjusted Return